Skip Nav Destination
A Randomized, Double-Blinded, Placebo-Controlled Phase II Trial of Recombinant Human Leukemia Inhibitory Factor (rhuLIF, emfilermin, AM424) to Prevent Chemotherapy-Induced Peripheral Neuropathy
Clin Cancer Res (2005) 11 (5): 1685–1686.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
- Thomas J. Kaley
- Lisa M. DeAngelis
British Journal of Haematology (2009) 145 (1): 3.
- Bushra Malik
- Mark Stillman
Current Neurology and Neuroscience Reports (2008) 8 (1): 56.
- Bushra Malik
- Mark Stillman
Current Pain and Headache Reports (2008) 12 (3): 165.
- Mark Stillman
- Juan P. Cata
Current Pain and Headache Reports (2006) 10 (4): 279.